Routine use of daily oral vitamin K to treat infants with cystic fibrosis
Routine use of daily oral vitamin K to treat infants with cystic fibrosis
Vitamin K is routinely administered after birth in the UK to prevent haemorrhagic disease of the newborn. Despite this, vitamin K-deficient coagulopathy still occurs in infants with high morbidity and mortality. Up to 50% of late onset bleeding presents with intracranial haemorrhage. The risk of developing vitamin K coagulopathy is higher in infants with cystic fibrosis (CF) and those that are exclusively breast fed due to low vitamin K levels in breast milk and intestinal changes in bacterial flora.Oral vitamin K supplementation is a simple addition to routine CF treatment during infancy to prevent complications from significant coagulopathy.
Cystic Fibrosis, Vitamin K
22-24
Cottam, Sophie T.
f8fbc413-a56b-472a-95ea-a5db9496b319
Connett, Gary J.
55d5676c-90d8-46bf-a508-62eded276516
1 October 2015
Cottam, Sophie T.
f8fbc413-a56b-472a-95ea-a5db9496b319
Connett, Gary J.
55d5676c-90d8-46bf-a508-62eded276516
Cottam, Sophie T. and Connett, Gary J.
(2015)
Routine use of daily oral vitamin K to treat infants with cystic fibrosis.
Paediatric Respiratory Reviews, 16 (Supplement 1), , [1062].
(doi:10.1016/j.prrv.2015.07.012).
Abstract
Vitamin K is routinely administered after birth in the UK to prevent haemorrhagic disease of the newborn. Despite this, vitamin K-deficient coagulopathy still occurs in infants with high morbidity and mortality. Up to 50% of late onset bleeding presents with intracranial haemorrhage. The risk of developing vitamin K coagulopathy is higher in infants with cystic fibrosis (CF) and those that are exclusively breast fed due to low vitamin K levels in breast milk and intestinal changes in bacterial flora.Oral vitamin K supplementation is a simple addition to routine CF treatment during infancy to prevent complications from significant coagulopathy.
This record has no associated files available for download.
More information
e-pub ahead of print date: 22 September 2015
Published date: 1 October 2015
Keywords:
Cystic Fibrosis, Vitamin K
Identifiers
Local EPrints ID: 419468
URI: http://eprints.soton.ac.uk/id/eprint/419468
ISSN: 1526-0542
PURE UUID: f6ba47a6-3f16-4c73-a2a4-34c8c1d4042c
Catalogue record
Date deposited: 12 Apr 2018 16:30
Last modified: 16 Mar 2024 04:35
Export record
Altmetrics
Contributors
Author:
Sophie T. Cottam
Author:
Gary J. Connett
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics